[
  {
    "ts": null,
    "headline": "Health Care Roundup: Market Talk",
    "summary": "Gain insight on Eli Lilly, WELL Health Technologies and more in the latest Market Talks covering the Health Care sector.",
    "url": "https://finnhub.io/api/news?id=326b107c277c17360d351d444d3c3f93f119d2cacf5a98651000511b9cd7cff6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755293460,
      "headline": "Health Care Roundup: Market Talk",
      "id": 136376139,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Gain insight on Eli Lilly, WELL Health Technologies and more in the latest Market Talks covering the Health Care sector.",
      "url": "https://finnhub.io/api/news?id=326b107c277c17360d351d444d3c3f93f119d2cacf5a98651000511b9cd7cff6"
    }
  },
  {
    "ts": null,
    "headline": "Why Novo Nordisk Flew Almost 3% Higher on Friday",
    "summary": "It seems to be holding off on price adjustments demanded by President Trump.",
    "url": "https://finnhub.io/api/news?id=863a0baa3d4c90e18e53141a71a02bce5ef999277b30aff38b61eea71fa873eb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755292509,
      "headline": "Why Novo Nordisk Flew Almost 3% Higher on Friday",
      "id": 136376140,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "It seems to be holding off on price adjustments demanded by President Trump.",
      "url": "https://finnhub.io/api/news?id=863a0baa3d4c90e18e53141a71a02bce5ef999277b30aff38b61eea71fa873eb"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500 Advances on Week as Likelihood of September Fed Rate-Cut Keeps Bulls Engaged",
    "summary": "The Standard & Poor's 500 index rose 0.9% this week, scaling new peaks in four consecutive trading s",
    "url": "https://finnhub.io/api/news?id=68666c595a39962776786ff8774b23e4652d4ae3bb0600eb886ed4adffeefb31",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755290124,
      "headline": "S&P 500 Advances on Week as Likelihood of September Fed Rate-Cut Keeps Bulls Engaged",
      "id": 136376141,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The Standard & Poor's 500 index rose 0.9% this week, scaling new peaks in four consecutive trading s",
      "url": "https://finnhub.io/api/news?id=68666c595a39962776786ff8774b23e4652d4ae3bb0600eb886ed4adffeefb31"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly raising GLP-1 prices abroad raises more questions about US pricing: BofA analyst",
    "summary": "Eli Lilly raises UK prices of GLP-1s in response to Most Favored Nations clause.",
    "url": "https://finnhub.io/api/news?id=060cedade4df2ff4edc46e71276466f100576bedbcb6be2d61fa9307de5eff5d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755285361,
      "headline": "Eli Lilly raising GLP-1 prices abroad raises more questions about US pricing: BofA analyst",
      "id": 136376142,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly raises UK prices of GLP-1s in response to Most Favored Nations clause.",
      "url": "https://finnhub.io/api/news?id=060cedade4df2ff4edc46e71276466f100576bedbcb6be2d61fa9307de5eff5d"
    }
  },
  {
    "ts": null,
    "headline": "Why Eli Lilly (LLY) Stock Is Up Today",
    "summary": "Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.2% in the afternoon session after the stock extended its positive momentum partly fueled by reports of major insider buying by top executives, including the CEO, which is often seen as a strong vote of confidence. Additionally, news that the company has signed a multi-billion dollar deal with an AI health tech company (Superluminal) to discover and develop new obesity medicines also contributed to the positive sentiment. Final",
    "url": "https://finnhub.io/api/news?id=ba2385232ffa40afd7cb16482b18dc005deab1381a2835805fd9371f7fbfa34e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755284150,
      "headline": "Why Eli Lilly (LLY) Stock Is Up Today",
      "id": 136376143,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.2% in the afternoon session after the stock extended its positive momentum partly fueled by reports of major insider buying by top executives, including the CEO, which is often seen as a strong vote of confidence. Additionally, news that the company has signed a multi-billion dollar deal with an AI health tech company (Superluminal) to discover and develop new obesity medicines also contributed to the positive sentiment. Final",
      "url": "https://finnhub.io/api/news?id=ba2385232ffa40afd7cb16482b18dc005deab1381a2835805fd9371f7fbfa34e"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly: Bet Against Insiders",
    "summary": "Eli Lilly insiders made notable stock purchases in August, but competitive pressures and pricing risks make me question its investment appeal. Read the full stock analysis here.",
    "url": "https://finnhub.io/api/news?id=be7d6d9793d850e3da7cba8ab412014878225a5b73cc49fabe216b605997ff22",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755283502,
      "headline": "Eli Lilly: Bet Against Insiders",
      "id": 136373317,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157849824/image_2157849824.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Eli Lilly insiders made notable stock purchases in August, but competitive pressures and pricing risks make me question its investment appeal. Read the full stock analysis here.",
      "url": "https://finnhub.io/api/news?id=be7d6d9793d850e3da7cba8ab412014878225a5b73cc49fabe216b605997ff22"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst",
    "summary": "On Thursday, Eli Lilly and Co. (NYSE:LLY) said it will sharply increase the list price of its weight-loss and type 2 diabetes drug Mounjaro (tirzepatide) in the United Kingdom. The moves underscore growing competition with Danish rival Novo Nordisk A/S (NYSE:NVO) in the lucrative obesity drug market. Starting in September, Lilly will raise the U.K. list price for Mounjaro’s highest monthly dose from 122 pounds to 330 pounds, a 170% jump, bringing it in line with prices in other European markets.",
    "url": "https://finnhub.io/api/news?id=18bdd9ae413a733a16bb9cf56f861f508663523495f89abd8f626f1e6978b78d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755280463,
      "headline": "Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst",
      "id": 136376144,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "On Thursday, Eli Lilly and Co. (NYSE:LLY) said it will sharply increase the list price of its weight-loss and type 2 diabetes drug Mounjaro (tirzepatide) in the United Kingdom. The moves underscore growing competition with Danish rival Novo Nordisk A/S (NYSE:NVO) in the lucrative obesity drug market. Starting in September, Lilly will raise the U.K. list price for Mounjaro’s highest monthly dose from 122 pounds to 330 pounds, a 170% jump, bringing it in line with prices in other European markets.",
      "url": "https://finnhub.io/api/news?id=18bdd9ae413a733a16bb9cf56f861f508663523495f89abd8f626f1e6978b78d"
    }
  },
  {
    "ts": null,
    "headline": "Texas Lawsuit Filed Against Eli Lilly (LLY) Amid New Cardio Collaboration",
    "summary": "Eli Lilly (LLY) recently faced legal challenges as Texas Attorney General Ken Paxton filed a lawsuit against the company, accusing it of bribery and inducement, which might weigh heavily on its reputation. Conversely, the announcement of a promising partnership with Superluminal Medicines to develop small molecule therapeutics and the launch of EBGLYSS may bolster its innovative efforts. Despite these mixed events, the company’s 6.8% share price increase over the last week was notable amidst...",
    "url": "https://finnhub.io/api/news?id=c866a3a61417d18e3bd023e09c2752c45574e59c9a1ea4f15886aa8538ccae92",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755278673,
      "headline": "Texas Lawsuit Filed Against Eli Lilly (LLY) Amid New Cardio Collaboration",
      "id": 136376145,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly (LLY) recently faced legal challenges as Texas Attorney General Ken Paxton filed a lawsuit against the company, accusing it of bribery and inducement, which might weigh heavily on its reputation. Conversely, the announcement of a promising partnership with Superluminal Medicines to develop small molecule therapeutics and the launch of EBGLYSS may bolster its innovative efforts. Despite these mixed events, the company’s 6.8% share price increase over the last week was notable amidst...",
      "url": "https://finnhub.io/api/news?id=c866a3a61417d18e3bd023e09c2752c45574e59c9a1ea4f15886aa8538ccae92"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk Stock Could Benefit From Eli Lilly’s Weight-Loss Price Hikes",
    "summary": "The pricing of weight-loss drugs like Lilly’s Zepbound and Novo’s Wegovy is a pressure point for investors.",
    "url": "https://finnhub.io/api/news?id=e3a8dc51ee79f90a7bf20705301b6a6af06724a693360fa14ead742ca6f05d48",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755275100,
      "headline": "Novo Nordisk Stock Could Benefit From Eli Lilly’s Weight-Loss Price Hikes",
      "id": 136376146,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The pricing of weight-loss drugs like Lilly’s Zepbound and Novo’s Wegovy is a pressure point for investors.",
      "url": "https://finnhub.io/api/news?id=e3a8dc51ee79f90a7bf20705301b6a6af06724a693360fa14ead742ca6f05d48"
    }
  },
  {
    "ts": null,
    "headline": "UK patients rush to buy obesity jab ahead of 170% price rise",
    "summary": "Patients are racing to secure the weight loss drug Mounjaro ahead of a price rise of up to 170 per cent in the UK, as drugmaker Eli Lilly responds...",
    "url": "https://finnhub.io/api/news?id=aee945e4bae63f4a4c0c55b104f06a04402be4db81889749de3b822b3cbc0e42",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755267246,
      "headline": "UK patients rush to buy obesity jab ahead of 170% price rise",
      "id": 136376147,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Patients are racing to secure the weight loss drug Mounjaro ahead of a price rise of up to 170 per cent in the UK, as drugmaker Eli Lilly responds...",
      "url": "https://finnhub.io/api/news?id=aee945e4bae63f4a4c0c55b104f06a04402be4db81889749de3b822b3cbc0e42"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly hikes Mounjaro prices in the UK to make weight-loss drug cheaper in the US",
    "summary": "Eli Lilly will significantly increase the price of its weight-loss drug Mounjaro in the United Kingdom in a bid to bring down prices in the United States after weeks of pressure from the Trump administration.",
    "url": "https://finnhub.io/api/news?id=feeb51589b342377f2bab8f63a62f6d0bbeaf7afce2f6828cb45e4281c2e387a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755265735,
      "headline": "Eli Lilly hikes Mounjaro prices in the UK to make weight-loss drug cheaper in the US",
      "id": 136376148,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly will significantly increase the price of its weight-loss drug Mounjaro in the United Kingdom in a bid to bring down prices in the United States after weeks of pressure from the Trump administration.",
      "url": "https://finnhub.io/api/news?id=feeb51589b342377f2bab8f63a62f6d0bbeaf7afce2f6828cb45e4281c2e387a"
    }
  },
  {
    "ts": null,
    "headline": "Veru Announces Novel Modified-Release Oral Formulation for Enobosarm",
    "summary": "VERU unveils a novel modified-release oral enobosarm to enhance fat loss while preserving lean mass in chronic weight loss management.",
    "url": "https://finnhub.io/api/news?id=53e9c999b461dd490324335c325638f96cce63fee0a2100a1754666972a900c1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755264000,
      "headline": "Veru Announces Novel Modified-Release Oral Formulation for Enobosarm",
      "id": 136369960,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "VERU unveils a novel modified-release oral enobosarm to enhance fat loss while preserving lean mass in chronic weight loss management.",
      "url": "https://finnhub.io/api/news?id=53e9c999b461dd490324335c325638f96cce63fee0a2100a1754666972a900c1"
    }
  },
  {
    "ts": null,
    "headline": "Will New CEO's Leadership Propel Novo Nordisk's Next Growth Wave?",
    "summary": "Maziar Mike Doustdar takes office as NVO's new CEO, bringing a proven global growth record to tackle rising obesity market competition.",
    "url": "https://finnhub.io/api/news?id=c69632aabfab67c14c9f0f90d10e380dd43f018205a30e9cb6791a8bfbc322da",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755263160,
      "headline": "Will New CEO's Leadership Propel Novo Nordisk's Next Growth Wave?",
      "id": 136370276,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Maziar Mike Doustdar takes office as NVO's new CEO, bringing a proven global growth record to tackle rising obesity market competition.",
      "url": "https://finnhub.io/api/news?id=c69632aabfab67c14c9f0f90d10e380dd43f018205a30e9cb6791a8bfbc322da"
    }
  },
  {
    "ts": null,
    "headline": "UK pharmacist says Eli Lilly’s Mounjaro price hike a “shock”",
    "summary": "Eli Lilly said the increase brings the UK price in line with other European markets, though NHS availability will be unaffected.",
    "url": "https://finnhub.io/api/news?id=7271eb476e2b8cb07115cb97326a84edb69b9f7ab0b6aced4a0eeca0bf6815d5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755258759,
      "headline": "UK pharmacist says Eli Lilly’s Mounjaro price hike a “shock”",
      "id": 136367934,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly said the increase brings the UK price in line with other European markets, though NHS availability will be unaffected.",
      "url": "https://finnhub.io/api/news?id=7271eb476e2b8cb07115cb97326a84edb69b9f7ab0b6aced4a0eeca0bf6815d5"
    }
  },
  {
    "ts": null,
    "headline": "3 Stocks Estimated To Be Trading Up To 40.8% Below Their Intrinsic Value",
    "summary": "As the U.S. stock market navigates a landscape marked by record highs and fluctuating inflation expectations, investors are keenly observing economic indicators that could influence Federal Reserve policy decisions. In this environment, identifying undervalued stocks—those trading below their intrinsic value—can provide opportunities for investors seeking to capitalize on potential market inefficiencies.",
    "url": "https://finnhub.io/api/news?id=10f78643defdf4ca57b4a621a109f6fe39940acf90e92be921ef9bcce9e4e23d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755257870,
      "headline": "3 Stocks Estimated To Be Trading Up To 40.8% Below Their Intrinsic Value",
      "id": 136367935,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "As the U.S. stock market navigates a landscape marked by record highs and fluctuating inflation expectations, investors are keenly observing economic indicators that could influence Federal Reserve policy decisions. In this environment, identifying undervalued stocks—those trading below their intrinsic value—can provide opportunities for investors seeking to capitalize on potential market inefficiencies.",
      "url": "https://finnhub.io/api/news?id=10f78643defdf4ca57b4a621a109f6fe39940acf90e92be921ef9bcce9e4e23d"
    }
  },
  {
    "ts": null,
    "headline": "Buffett Stock Buys Say Plenty About the Stock Market. Why His Inaction Says More.",
    "summary": "Trump’s Putin meeting crucial for oil prices, Berkshire Hathaway’s mystery solved, the case for rate cuts, and more news to start your day.",
    "url": "https://finnhub.io/api/news?id=e72e73abe2aff0f4ce547a071ff5c3ede5021fba43caa47fd1e971eb55c0e5c4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755254400,
      "headline": "Buffett Stock Buys Say Plenty About the Stock Market. Why His Inaction Says More.",
      "id": 136367936,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Trump’s Putin meeting crucial for oil prices, Berkshire Hathaway’s mystery solved, the case for rate cuts, and more news to start your day.",
      "url": "https://finnhub.io/api/news?id=e72e73abe2aff0f4ce547a071ff5c3ede5021fba43caa47fd1e971eb55c0e5c4"
    }
  },
  {
    "ts": null,
    "headline": "S&P Futures Tick Higher With Focus on U.S. Retail Sales Data and Trump-Putin Meeting",
    "summary": "September S&P 500 E-Mini futures (ESU25) are trending up +0.17% this morning, bolstered by continued hopes for a Federal Reserve rate cut next month, while investors await U.S. retail sales data and high-stakes talks between U.S. President Donald Trump and Russia’s Vladimir Putin.",
    "url": "https://finnhub.io/api/news?id=68b1eb5d0d57455e40a30f9e3b67fec846642779d6d2c49e61cb77c97876b555",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755252136,
      "headline": "S&P Futures Tick Higher With Focus on U.S. Retail Sales Data and Trump-Putin Meeting",
      "id": 136367937,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "September S&P 500 E-Mini futures (ESU25) are trending up +0.17% this morning, bolstered by continued hopes for a Federal Reserve rate cut next month, while investors await U.S. retail sales data and high-stakes talks between U.S. President Donald Trump and Russia’s Vladimir Putin.",
      "url": "https://finnhub.io/api/news?id=68b1eb5d0d57455e40a30f9e3b67fec846642779d6d2c49e61cb77c97876b555"
    }
  },
  {
    "ts": null,
    "headline": "Big Pharma Has a New Vision for Selling Drugs. It’s Going to the Mattresses.",
    "summary": "Big Pharma Has a New Vision for Selling Drugs. It’s Going to the Mattresses.",
    "url": "https://finnhub.io/api/news?id=6ca68a671073863d4448e6ae59763b15bbd8fe6d65164e398d99049750d5395d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755142200,
      "headline": "Big Pharma Has a New Vision for Selling Drugs. It’s Going to the Mattresses.",
      "id": 136354466,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Big Pharma Has a New Vision for Selling Drugs. It’s Going to the Mattresses.",
      "url": "https://finnhub.io/api/news?id=6ca68a671073863d4448e6ae59763b15bbd8fe6d65164e398d99049750d5395d"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Says He is “Very Upset” With Eli Lilly",
    "summary": "Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently discussed. When a caller inquired about the company during the lightning round, Cramer commented: “Down here, I begin to think that we are too negative on it, but I am very upset with Lilly in the way they handled this, and I […]",
    "url": "https://finnhub.io/api/news?id=4580a7a62a5fcffab3331b01fc982743109d35047b8c7341cc74d17cd6446b47",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755240820,
      "headline": "Jim Cramer Says He is “Very Upset” With Eli Lilly",
      "id": 136367938,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently discussed. When a caller inquired about the company during the lightning round, Cramer commented: “Down here, I begin to think that we are too negative on it, but I am very upset with Lilly in the way they handled this, and I […]",
      "url": "https://finnhub.io/api/news?id=4580a7a62a5fcffab3331b01fc982743109d35047b8c7341cc74d17cd6446b47"
    }
  }
]